Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider and approve ,inter alia amongst other ....
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has informed the stock exchanges that its Board of Directors will meet on Wednesday, July 23, 2025. The main item on the agenda is to decide on the 'mode of rewarding of shareholders' as described in the explanatory statement of item no. 3 of the 2025-26/01st Extraordinary General Meeting notice. The Board may also issue a corrigendum related to that item. The notice is filed under SEBI Listing Regulations 29 and 30.
This is a forward-looking intimation rather than a final decision. Shareholders should watch for the outcome on July 23, as it could lead to a dividend, bonus issue, stock split, or buyback, which would affect the stock price.